An OHSU study finds that when both cannabis and nicotine are used during pregnancy, the rate of infant death increases fourfold. “With the growing legalization of cannabis around the country, there is often a perception that cannabis is safe in pregnancy,” says Jamie Lo, M.D. "Our hope is that this research supports more open and productive conversations that ultimately result in a healthier pregnancy.”

A Phase I/II clinical trial finds that a CRISPR-based gene editing technology improved vision in 11 of 14 participants who were born with a blindness-causing gene mutation. Mark Pennesi, M.D., Ph.D., says, “As ophthalmologists, we were often taught that there aren't really treatments for these rare genetic diseases. That is changing."

Mitchell Hayes, M.D., gives a presentation at the American Urological Association meeting on his team’s work using advanced techniques to study tumor samples from patients with localized renal cell carcinoma.

A Phase I/II clinical trial finds that a CRISPR-based gene editing technology improved vision in 11 of 14 participants who were born with a blindness-causing gene mutation. Mark Pennesi, M.D., Ph.D., says, “As ophthalmologists, we were often taught that there aren't really treatments for these rare genetic diseases. That is changing."

A Phase I/II clinical trial finds that a CRISPR-based gene editing technology improved vision in 11 of 14 participants who were born with a blindness-causing gene mutation. Mark Pennesi, M.D., Ph.D., says, “As ophthalmologists, we were often taught that there aren't really treatments for these rare genetic diseases. That is changing."

A Phase I/II clinical trial finds that a CRISPR-based gene editing technology improved vision in 11 of 14 participants who were born with a blindness-causing gene mutation. Mark Pennesi, M.D., Ph.D., says, “As ophthalmologists, we were often taught that there aren't really treatments for these rare genetic diseases. That is changing."

A Phase I/II clinical trial finds that a CRISPR-based gene editing technology improved vision in 11 of 14 participants who were born with a blindness-causing gene mutation. Mark Pennesi, M.D., Ph.D., says, “As ophthalmologists, we were often taught that there aren't really treatments for these rare genetic diseases. That is changing."

A Phase I/II clinical trial finds that a CRISPR-based gene editing technology improved vision in 11 of 14 participants who were born with a blindness-causing gene mutation. Mark Pennesi, M.D., Ph.D., says, “As ophthalmologists, we were often taught that there aren't really treatments for these rare genetic diseases. That is changing."

An OHSU study that finds Mount Washington ranked No. 7 in number of accidents and fourth in deaths among U.S. peaks during a roughly 70-year span is cited in a Wall Street Journal story about the mountain.

Cindy McEvoy, M.D., presents at the Pediatric Academic Societies 2024 Meeting about a study that finds extending the use of a CPAP treatment in premature infants by two weeks significantly increases lung volume and lung diffusion capacity. “The study’s findings solidify CPAP treatment as beneficial for preterm infants without requiring pharmaceuticals,” she says.